Tandem Diabetes Care Inc (NASDAQ:TNDM) closed Friday at $29.49 per share, up from $29.36 a day earlier. While Tandem Diabetes Care Inc has overperformed by 0.44%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TNDM fell by -30.64%, with highs and lows ranging from $47.17 to $13.82, whereas the simple moving average jumped by 5.80% in the last 200 days.
On August 04, 2023, Citigroup Downgraded Tandem Diabetes Care Inc (NASDAQ: TNDM) to Neutral.
Analysis of Tandem Diabetes Care Inc (TNDM)
Further, the quarter-over-quarter decrease in sales is -9.25%, showing a negative trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Tandem Diabetes Care Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -56.66% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.28, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and TNDM is recording an average volume of 1.70M. On a monthly basis, the volatility of the stock is set at 5.91%, whereas on a weekly basis, it is put at 3.99%, with a gain of 3.00% over the past seven days. Furthermore, long-term investors anticipate a median target price of $31.33, showing growth from the present price of $29.49, which can serve as yet another indication of whether TNDM is worth investing in or should be passed over.
How Do You Analyze Tandem Diabetes Care Inc Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.67%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 108.29% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in TNDM shares?
The recent increase in stakes in TNDM appears to be a result of several institutional investors and hedge funds increasing their positions. BlackRock Fund Advisors’s position in TNDM has decreased by -0.42% in the first quarter. The company now owns 8,051,631 shares of the stock, with a value of $162.97 million, following the sale of -33,829 additional shares during the last quarter. The Vanguard Group, Inc. made another decreased to its shares in TNDM during the first quarter, downing its stake by -0.13%. During the last quarter, the company picked up -8,700 additional shares for a total stake of worth $139.91 million, bringing number of shares owned by the company to 6,912,667.
During the first quarter, Capital Research & Management Co added a 59,311 position in TNDM. Eminence Capital LP purchased an additional 2.37 million shares in the last quarter, increasing its holdings by 76.10%, now holding 5.49 million shares worth $111.12 million. At the end of the first quarter, Janus Henderson Investors US LLC increased its TNDM holdings by 28.52% and now holds 2.64 million TNDM shares valued at $53.44 million with the added 0.59 million shares during the period. TNDM shares are owned by institutional investors to the tune of 108.29% at present.